PCSK9 imperceptibly affects chemokine receptor expression in vitro and in vivo. (August 2022)

Record Type:: Journal Article
Title:: PCSK9 imperceptibly affects chemokine receptor expression in vitro and in vivo. (August 2022)
Main Title:: PCSK9 imperceptibly affects chemokine receptor expression in vitro and in vivo
Authors:: Sundararaman, S.S.
Peters, L.
Nazir, S.
Bonnin-Marquez, A.
Bouma, J.E.
Bayasgalan, S.
Doering, Y.
Van Der Vorst, E.
Abstract:
Is Part Of:: Atherosclerosis. Volume 355(2022)
Journal:: Atherosclerosis
Issue:: Volume 355(2022)
Issue Display:: Volume 355, Issue 2022 (2022)
Year:: 2022
Volume:: 355
Issue:: 2022
Issue Sort Value:: 2022-0355-2022-0000
Page Start:: 24
Page End:
Publication Date:: 2022-08
Subjects:: Arteriosclerosis -- Periodicals
Electronic journals
616.136
Journal URLs:: http://www.sciencedirect.com/science/journal/00219150 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/00219150 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/j.atherosclerosis.2022.06.301 ↗
Languages:: English
ISSNs:: 0021-9150
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 1765.874000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 23301.xml